[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351260-105":59,"doc-detail-351260-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gold-nanoparticles-in-bladder-cancer-applications-a-paradigm-shift-from-diagnostic-tools-to-integrated-theranostic-platforms","Gold Nanoparticles in Bladder Cancer Applications - A Paradigm Shift from Diagnostic Tools to Integrated Theranostic Platforms","","Gold nanoparticles are presented as multifunctional platforms to address persistent clinical challenges in bladder cancer, especially non-muscle-invasive disease with high recurrence and limited diagnostic sensitivity. The review synthesizes principles and mechanisms supported by recent literature, covering ultra-sensitive biosensing for urinary biomarkers, multimodal molecular imaging contrast, photothermal tumor ablation, targeted drug delivery to reduce chemoresistance, radiotherapy sensitization, and immunosuppressive microenvironment remodeling. Remaining barriers include preclinical dependence and the need for long-term biosafety and standardized production before broad clinical adoption.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gold-nanoparticles-in-bladder-cancer-applications-a-paradigm-shift-from-diagnostic-tools-to-integrated-theranostic-platforms/351260/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gold-nanoparticles-in-bladder-cancer-applications-a-paradigm-shift-from-diagnostic-tools-to-integrated-theranostic-platforms/351260.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are bladder cancer diagnostics and treatments still challenging for NMIBC?","Question",{"text":112,"@type":113},"NMIBC has high recurrence rates, and traditional diagnostics such as cystoscopy and urine cytology are limited by invasiveness or insufficient sensitivity, especially for low-grade disease.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What diagnostic roles do gold nanoparticles play?",{"text":117,"@type":113},"AuNP-based biosensors enable ultra-sensitive detection of urinary biomarkers, and AuNPs act as contrast agents to improve visualization in imaging.",{"name":119,"@type":110,"acceptedAnswer":120},"How do gold nanoparticles support therapeutic strategies in bladder cancer?",{"text":121,"@type":113},"They can mediate photothermal therapy for precise tumor ablation, serve as drug carriers to help overcome chemoresistance, and show potential for remodeling the immunosuppressive tumor microenvironment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351260,1790637375,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","International Journal of Nanomedicine  \n Open Access Full Text Article  \nREVIEW  \nGold Nanoparticles in Bladder Cancer Applications: A Paradigm Shift from Diagnostic Tools to Integrated Theranostic Platforms  \nXuwei Zhang 1 , Xiaochui Wu 1 , Jiancheng Du2 , Jianfeng Mei 3 , Fei Chen 3 , Kecheng Lou 1  \n1Department of Urology, Lanxi People’s Hospital, Jinhua, Zhejiang, People’s Republic of China; 2Department of Intensive Care Unit, Lanxi People’s Hospital, Jinhua, Zhejiang, People’s Republic of China; 3Department of General Surgery, Lanxi People’s Hospital, Jinhua, Zhejiang, People’s Republic of China  \nCorrespondence: Kecheng Lou, Email [18329037615@163.com](18329037615@163.com)  \n\n| Background: Bladder cancer, particularly non-muscle-invasive bladder cancer (NMIBC), poses significant clinical challenges due to its high recurrence rate. Traditional diagnostic approaches such as cystoscopy and urine cytology have limitations, including invasiveness and insufficient sensitivity. Gold nanoparticles (AuNPs) offer unique opportunities to address these challenges with their surface plasmon resonance effect, biocompatibility, and ease of functionalization.\u003Cbr>Methods: Through critical review of recent literature, this paper outlines the application principles, achievements, and mechanisms of AuNPs in bladder cancer, including in vitro diagnostics, multimodal molecular imaging, photothermal therapy, targeted drug delivery, radiotherapy sensitization, and tumor immune microenvironment remodeling.\u003Cbr>Main Findings: AuNPs are driving a paradigm shift in bladder cancer management. In diagnostics, AuNP-based biosensors enable ultra-sensitive detection of urinary biomarkers. In imaging, they serve as effective contrast agents for enhanced visualization. For therapy, AuNP-mediated photothermal therapy enables precise tumor ablation, and as drug carriers, they help overcome chemoresistance. Additionally, AuNPs demonstrate potential in remodeling the immunosuppressive microenvironment through modulation of signaling pathways and tumor-associated macrophages.\u003Cbr>Conclusion: Gold nanoparticles are transforming bladder cancer toward precision, minimally invasive, and personalized treatment models. However, it is important to acknowledge that most current findings remain in the preclinical stage, and significant translational barriers—particularly long-term biosafety and standardized production—must be addressed before widespread clinical adoption. Keywords: gold nanoparticles, bladder cancer, non-invasive diagnosis, drug delivery, tumor microenvironment, nanomedicine |\n| --- |\n| Introduction\u003Cbr>Bladder cancer ranks as the tenth most common malignancy worldwide, with over 570,000 new cases and more than 210,000 deaths annually.1 Among these, NMIBC accounts for 70–80% of initial diagnoses. Although transurethral resection of bladder tumor (TURBT) combined with postoperative intravesical chemotherapy or immunotherapy can achieve favorable outcomes, 50–70% of patients experience recurrence within five years, with 10–30% progressing to muscle-invasive bladder cancer (MIBC) .2 This “recurrence-treatment-recurrence” cycle consumes substantial medical resources and imposes significant physical and psychological burdens on patients. Traditional cystoscopy combined with urine cytology remains the gold standard for bladder cancer diagnosis and monitoring. However, cystoscopy is invasive, costly, and may cause complications, while urine cytology exhibits low sensitivity, particularly for low-grade bladder cancer.3 Therefore, developing non-invasive, highly sensitive diagnostic methods and efficient, specific therapeutic strategies has become a critical need in bladder cancer research.\u003Cbr>In this context, gold nanoparticles (AuNPs) have shown tremendous potential. As a prominent member of the metal nanoparticle family, AuNPs offer a versatile platform compared to other metallic systems due to their superior stability and tunable surface chemistry.4–6 Their ap","cbCaibyhObldM4vP","https://ap.wps.com/l/cbCaibyhObldM4vP","pdf",2058543,14,"English","# Background\n# Methods\n# Main Findings\n# Conclusion\n# Introduction","[{\"question\":\"Why are bladder cancer diagnostics and treatments still challenging for NMIBC?\",\"answer\":\"NMIBC has high recurrence rates, and traditional diagnostics such as cystoscopy and urine cytology are limited by invasiveness or insufficient sensitivity, especially for low-grade disease.\"},{\"question\":\"What diagnostic roles do gold nanoparticles play?\",\"answer\":\"AuNP-based biosensors enable ultra-sensitive detection of urinary biomarkers, and AuNPs act as contrast agents to improve visualization in imaging.\"},{\"question\":\"How do gold nanoparticles support therapeutic strategies in bladder cancer?\",\"answer\":\"They can mediate photothermal therapy for precise tumor ablation, serve as drug carriers to help overcome chemoresistance, and show potential for remodeling the immunosuppressive tumor microenvironment.\"}]","Gold Nanoparticles in Bladder Cancer Applications - A Paradigm Shift from Diagnostic Tools to Integrated Theranostic Platforms | PDF",1790093262,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4321e34a10d550de7f099b3d612ccc79.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d98391dc6b3a282eab2174aa282a537c.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/152cf7dc601dad9d9ff3dc09753c0854.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c70c8e5e839abaeb87f33049df1ec329.webp",980,1268]